The University of Nottingham's Division of Drug Delivery and Tissue Engineering (website) has built state-of-the-art laboratories within the £6million-JIF funded School of Pharmacy. This comprises extensive tissue culture facilities (including a suite dedicated to stem cell culture), gel-electrophoresis equipment, RT-PCR, immunocytochemistry/histology and a microscopy suite (includes image processing/analysis). Additional facilities include confocal microscopy, scanning and transmission electron microscopy and atomic force microscopy. We have access to wide range of analytical chemistry and separation equipment including time-of-flight secondary ion mass spectrometry, X-ray photoelectron spectroscopy, surface plasmon resonance and high-performance liquid chromatography.

The University of Nottingham has made large investment in stem cell science and tissue engineering over the past three years. It has developed a Stem Cell Cluster which brings together clinicians, clinical scientists, cell and molecular biologists and engineers from a range of Schools across the University.

The University of Nottingham's contribution to the Osteocord project is in the responsibility for studies with ES cells and comparative assessments with CB-MSCs and BM-MSCs and their osteogenic potential. Two human ES cell lines currently established at the University will be available to the project.

Division of Drug Delivery and Tissue Engineering, School of Pharmacy, University of Nottingham, University Park, Nottingham, NG7 2RD, UK

Dr Lee Buttery e-mail	Dr Matthew Tomlinson e-mail

Click on the links to access the other Partners:

1. University of York, UK
2. University Hospital of Odense, Denmark
3. University of Southern Denmark
4. Fraunhofer Institute for Biomedical Engineering
5. University of Nottingham, UK
6. Institute of Transfusion Medicine and Immunology, Mannheim, Germany
7. Angel Biotechnology, Edinburgh, Scotland
8. EC Bio, Oeiras, Portugal
9. Regentec, Nottingham, UK